New York Life Investment Management »

Intra Cellular Therapies shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $9.5M 72k 131.92
2024-09-30 $823k 11k 73.17
2024-06-30 $745k 11k 68.49
2024-03-31 $684k 9.9k 69.20
2023-12-31 $763k 11k 71.62

More positions owned by New York Life Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
New York Life Invts Active E Nyli Mackay Core (CPLB)
New York Life Investments Et Candriam Us Lrg (IQSU)
Meta Platforms Cl A (META)
Broadcom (AVGO)
New York Life Investments Et Candriam Us Mid (IQSM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Vanguard World Mega Cap Index (MGC)
New York Life Investments Et Nyli Candriam In (IQSI)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Fltg Rate Nt Etf (FLOT)

View all positions for New York Life Investment Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies